The immunobiology of corneal transplantation

Keryn Williams, Douglas J. Coster

Research output: Contribution to journalReview article

71 Citations (Scopus)

Abstract

Corneal allotransplantation is highly successful in the short term, but much less successful in the longer term. Many corneal grafts in recipients with corneal neovascularization or the sequelae of ocular inflammation undergo irreversible rejection, despite topical immunosuppression with glucocorticosteroids. Sensitization to cornea-derived alloantigen proceeds by both direct and indirect routes, but the anatomic location of sensitization remains unclear. Multiple and redundant mechanisms operate in the effector phase of corneal graft rejection, which is largely cell-mediated rather than antibody-mediated. Human leukocyte antigen matching may improve outcomes in high-risk patients but systemic immunosuppression is frequently ineffective and is seldom used.

LanguageEnglish
Pages806-813
Number of pages8
JournalTransplantation
Volume84
Issue number7
DOIs
Publication statusPublished - 1 Oct 2007
Externally publishedYes

Keywords

  • Corneal transplantation
  • Immunosuppression
  • Rejection
  • Tissue matching

ASJC Scopus subject areas

  • Transplantation

Cite this

Williams, Keryn ; Coster, Douglas J. / The immunobiology of corneal transplantation. In: Transplantation. 2007 ; Vol. 84, No. 7. pp. 806-813.
@article{2fc18fc9178d4771b647129a76b566f0,
title = "The immunobiology of corneal transplantation",
abstract = "Corneal allotransplantation is highly successful in the short term, but much less successful in the longer term. Many corneal grafts in recipients with corneal neovascularization or the sequelae of ocular inflammation undergo irreversible rejection, despite topical immunosuppression with glucocorticosteroids. Sensitization to cornea-derived alloantigen proceeds by both direct and indirect routes, but the anatomic location of sensitization remains unclear. Multiple and redundant mechanisms operate in the effector phase of corneal graft rejection, which is largely cell-mediated rather than antibody-mediated. Human leukocyte antigen matching may improve outcomes in high-risk patients but systemic immunosuppression is frequently ineffective and is seldom used.",
keywords = "Corneal transplantation, Immunosuppression, Rejection, Tissue matching",
author = "Keryn Williams and Coster, {Douglas J.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1097/01.tp.0000285489.91595.13",
language = "English",
volume = "84",
pages = "806--813",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

The immunobiology of corneal transplantation. / Williams, Keryn; Coster, Douglas J.

In: Transplantation, Vol. 84, No. 7, 01.10.2007, p. 806-813.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The immunobiology of corneal transplantation

AU - Williams, Keryn

AU - Coster, Douglas J.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Corneal allotransplantation is highly successful in the short term, but much less successful in the longer term. Many corneal grafts in recipients with corneal neovascularization or the sequelae of ocular inflammation undergo irreversible rejection, despite topical immunosuppression with glucocorticosteroids. Sensitization to cornea-derived alloantigen proceeds by both direct and indirect routes, but the anatomic location of sensitization remains unclear. Multiple and redundant mechanisms operate in the effector phase of corneal graft rejection, which is largely cell-mediated rather than antibody-mediated. Human leukocyte antigen matching may improve outcomes in high-risk patients but systemic immunosuppression is frequently ineffective and is seldom used.

AB - Corneal allotransplantation is highly successful in the short term, but much less successful in the longer term. Many corneal grafts in recipients with corneal neovascularization or the sequelae of ocular inflammation undergo irreversible rejection, despite topical immunosuppression with glucocorticosteroids. Sensitization to cornea-derived alloantigen proceeds by both direct and indirect routes, but the anatomic location of sensitization remains unclear. Multiple and redundant mechanisms operate in the effector phase of corneal graft rejection, which is largely cell-mediated rather than antibody-mediated. Human leukocyte antigen matching may improve outcomes in high-risk patients but systemic immunosuppression is frequently ineffective and is seldom used.

KW - Corneal transplantation

KW - Immunosuppression

KW - Rejection

KW - Tissue matching

UR - http://www.scopus.com/inward/record.url?scp=38449117237&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000285489.91595.13

DO - 10.1097/01.tp.0000285489.91595.13

M3 - Review article

VL - 84

SP - 806

EP - 813

JO - Transplantation

T2 - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -